Indication

Wilms' tumor

Wilms' tumor, also known as nephroblastoma, is a primary malignant embryonal renal neoplasm that predominantly affects young children, typically presenting before five years of age. Read more about Wilms' tumor

41 drugs 33 manufacturers

Advertisement

Drugs that treat it

Common Wilms' tumor therapies.

Showing 19–27 of 41 drugs

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
APP/FRESENIUS K

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
Actavis Pharma

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
ATHENEX PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Wilms' tumor preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Wilms' tumor.

Wilms' tumor, also known as nephroblastoma, is a primary malignant embryonal renal neoplasm that predominantly affects young children, typically presenting before five years of age.

Pathophysiologically, it arises from persistent metanephric blastema and classically demonstrates a triphasic histology comprising blastemal, epithelial, and stromal cell lineages, often associated with genetic alterations such as mutations or deletions in the *WT1* gene.

Clinically, affected patients most commonly present with an asymptomatic, firm, unilateral abdominal mass, which may be accompanied by abdominal pain, hematuria, hypertension, or systemic symptoms such as fever.

Personalize your experience

Follow Wilms' tumor and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it